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Abstract: We describe here the clinical manifestations of platypnea-orthodeoxia in two patients with interatrial shunting. 
In both cases, the patients were asymptomatic prior to developing additional cardiopulmonary issues that apparently enhanced 
right-to-left intracardiac shunting. The patients were both treated with percutaneously deployed occlusion devices, with 
excellent results. Symptoms and positional oxygen desaturation resolved after device placement in both cases. In addition, 
these patients remain symptom-free 30 months after device implantation.
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Introduction
Platypnea-orthodeoxia syndrome is deﬁ  ned by clinically observable dyspnea and decrease in arterial 
blood oxygen saturation that is most prominent when the patient is sitting or standing, and resolves 
when the patient is supine. This syndrome, ﬁ  rst reported in 1949, may result from a number of cardio-
pulmonary processes, but is classically described as being the result of shunting of deoxygenated blood 
from the right atrium to the left atrium through an opening in the interatrial septum, most commonly a 
patent foramen ovale (PFO).
1 Atrial septal defect (ASD) and atrial septal aneurysm (ASA) are less 
commonly implicated.
2
The physiologic mechanism responsible for the positional nature of shunting is not fully understood. 
Under normal circumstances, left atrial pressure is 5–8 mmHg higher than right atrial pressure: this 
pressure difference is thought to prohibit right-to-left shunting through a PFO or small ASD, thus 
decreasing the likelihood of entrance of deoxygenated blood into the systemic circulation. Transient 
shunting of blood from the right atrium to the left may occur during speciﬁ  c circumstances, such as the 
Valsalva maneuver. Generally speaking, shunting sufﬁ  ciently sustained to produce platypnea-orthodeoxia 
is not always present in patients with a PFO or a small ASD.
2 This stands to reason, as platypnea-
orthodeoxia syndrome is quite rare, and PFO is thought to be present in as much as 25% o f the general 
population. Conditions that lead to an increase in right heart pressures can increase the right-to-left 
shunting and may lead to platypnea-orthodeoxia syndrome in previously asymptomatic people. A number 
of disease states have been shown to increase right atrial pressures above left atrial pressures, including: 
kyphoscoliosis, pulmonary vascular hypertension, and surgical lung resection.
3,4 Pulmonary arteriove-
nous malformations (AVMs) have also been associated with increased right-to-left shunting with or 
without a PFO.
5,6 Constrictive pericarditis and constrictive-effusive pericardial disease may also increase 
right heart pressures sufﬁ  ciently to enhance right-to-left shunting through a pre-existing PFO.
7 It is 
noteworthy that not all patients with persistent right-to-left shunting will have right heart pressures in 
excess of the normal range. Alteration of atrial geometry may also enhance the communication between 
the atria, potentially leading to right atrial remodeling and persistent shunting: such conditions include 
aneurismal expansion or elongation of the ascending aorta.
8,9 Platypnea-orthodeoxia syndrome may 
also be caused by an intrapulmonary shunt, as is seen in the hepatopulmonary syndrome. In rare cases, 
primary pulmonary processes such as severe COPD, pulmonary embolus, or ARDS, can lead to a right-
to-left shunt signiﬁ  cant enough to lead to clinically evident platypnea-orthodeoxia.
2
The diagnosis of platypnea-orthodeoxia syndrome is sometimes difﬁ  cult to establish deﬁ  nitively at 
the bedside, as not all patients with interatrial shunting will present with clear postural changes in 38
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blood oxygen saturation. In some cases, the use of 
supplemental oxygen therapy may aid in the estab-
lishment of the diagnosis, as a right-to-left atrial 
shunt will prevent systemic oxygen saturation from 
reaching 100% even with additional inhaled 
oxygen. Frequently, imaging is required to make 
the diagnosis: echocardiography with Doppler 
mode and contrast injection is the most widely used 
modality for this purpose. Ideally, image procure-
ment is performed with the patient in both the 
supine and upright positions.
We describe here the cases of two adults with 
platypnea-orthodeoxia syndrome who were treated 
at the Massachusetts General Hospital. In each 
case, the patient was asymptomatic and fully func-
tional prior to an acute insult that led to a subacute 
increase in right heart pressures, which in turn led 
to an apparent increase in right-to-left shunting.
Case #1
An 84-year-old woman with no previously reported 
cardiac or pulmonary disease was admitted due to 
progressive dyspnea over the course of four 
months. She had previously been very healthy, and 
had been engaged in daily physical labor until her 
symptoms prevented her from working. Her 
relatives reported that the patient had taken to bed, 
as her symptoms progressed to the point where 
even simple tasks around the home were exhausting. 
The patient and her relatives did not endorse any 
history of signs or symptoms that would raise 
concern for a respiratory illness: she reported only 
an intermittent, dry cough. There were no sick 
contacts or prior history of tuberculosis. The 
patient also did not endorse exertional chest dis-
comfort or other symptoms that might suggest an 
anginal syndrome. She denied experiencing any 
fevers, but she did report cold insensitivity and 
brittle hair during this period.
On her initial evaluation, her blood oxygen 
saturation was noted to be low (96%) even with 
supplemental oxygen therapy (100% oxygen, deliv-
ered via face mask). Her other vital signs were 
normal. She was noted to be quite comfortable 
while supine, but quickly tired when she attempted 
to walk. Ambulatory oxygen monitoring revealed 
that her blood oxygen would drop to 86% within 
one minute after standing, even with face mask 
oxygen. Ambulation did not tend to lead to further 
drops in blood saturation. Similarly, rest while 
standing did not lead to recovery of her blood 
saturation: only return to a supine position led to 
recovery. Pulmonary auscultation revealed good air 
movement throughout both lung ﬁ  elds with clear 
breath sounds. Her neck veins were elevated to 
10 cm H2O, but there was no other evidence of heart 
failure: no peripheral edema or clubbing was present. 
Cardiac auscultation revealed distant heart sounds 
with no extra heart sounds, rubs, or murmurs.
Further evaluation included a chest x-ray, which 
revealed an enlarged cardiac silhouette but no 
abnormalities in the lung ﬁ  elds. ECG was within 
normal limits. Laboratory evaluation revealed no 
signiﬁ  cant abnormality on Chemistry or complete 
blood count, but the thyroid stimulating hormone 
(TSH) level was markedly elevated at 46.5. Based on 
the presence of an enlarged cardiac silhouette on chest 
x-ray, a chest CT with contrast was performed. 
This study did not reveal any evidence of lung 
parenchymal abnormality or airspace disease. The 
pulmonary vasculature was also normal, with no 
evidence of pulmonary emboli, enlarged vessels, or 
arteriovenous malformations (AVMs). The cardiac 
structure did not appear grossly abnormal, but a 
moderate, circumferential pericardial effusion was 
noted. Based on this ﬁ  nding, a transthoracic echocar-
diogram (TTE) was performed. It is noteworthy that 
there was no clinical evidence of tamponade: the 
pulsus paradoxus was 5 mmHg. Left ventricular func-
tion was noted to be normal on the TTE, with no focal 
wall motion abnormalities. Both the right atrium (RA) 
and right ventricle (RV) were mildly compressed in 
early diastole, apparently due to the pressure from the 
pericardial ﬂ  uid (Fig. 1A). No pericardial or extra-
cardiac masses were found. Right ventricular systolic 
pressure was estimated to be in the high end of the 
normal range, based on the velocity of the tricuspid 
regurgitant jet. Doppler images of the interatrial 
septum revealed bidirectional shunting, with 
predominant right-to-left shunting through an apparent 
PFO/ASD (Fig. 1B). Images were obtained with the 
patient in the semirecumbent position: she did not 
tolerate image acquisition in the standing position.
Hypothyroidism was presumed to be the etiology 
of the pericardial effusion, as no other cause was 
evident. Based on the degree of right heart 
compression on TTF and clinical evidence of right-
to-left interatrial shunting, it was thought that urgent 
treatment was indicated. As the pericardial effusion 
was thought to be the precipitant of the right-to-left 
shunting, the patient was brought to the cardiac 
catheterization lab for pericardiocentesis. The hope 
was that decompression of the pericardial sac would 39
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Figure 1. Panel A) TTE, parasternal long-axis view: a moderate, circumferential pericardial effusion is visible, with no evidence of pericardial 
mass or signiﬁ  cant ﬁ  brin deposition (arrow). The silhouette of the right ventricular outﬂ  ow tract, marked RV, reveals inversion of the free wall, 
indicating an increase in pericardial pressure. The left ventricle (marked LV) is also clearly visible in this view. Panel B) TTE, subcostal view 
with Doppler: the right atrium is marked RA and the left atrium is marked LA. The Doppler scan reveals a jet moving away (colored blue) 
from the probe, from the right to the left atrium.40
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decrease right heart pressures and decrease the 
extent of right-to-left shunting. Right heart catheter-
ization performed at the time of pericardiocentesis 
revealed elevated right atrial pressures (13 mmHg 
mean). The opening pressure of the pericardial sac 
was 15 mmHg. One-hundred seventy ml of straw-
colored ﬂ  uid was collected: right atrial pressure 
was reduced to 7 mmHg and pericardial pressure 
was reduced to 0 mmHg. Further analysis of this 
ﬂ  uid revealed that it was transudative, with no 
evidence of infection or malignancy.
After drainage of the pericardial ﬂ  uid, the patient 
was improved, but not back to her prior baseline. 
Her oxygen saturation while supine was 98% with 
100% O2 delivered via face mask. In the standing 
position, her oxygen saturation dropped to 90%. 
A repeat TTE revealed a bidirectional shunt, with 
predominant right-to-left shunt with no change in 
her estimated right ventricular systolic pressure. The 
patient remained symptomatic with standing and 
ambulation, and was comfortable only when supine. 
Therefore, it was determined that her PFO would 
need to be closed in order to resolve her shunt.
The patient was brought back to the cardiac 
catheterization lab, for occlusion of her PFO with 
a percutaneously deployed (Amplatzer) occlusion 
device. Intra-procedural transesophageal echocar-
diography (TEE) and angiography revealed a mobile 
interatrial septum (Figs. 2A, 2B). As intraprocedural 
TEE could only be performed in the supine position, 
only the left-to-right component of the apparently 
bidirectional shunt could be visualized (Fig. 2C). 
An intraprocedural angiogram, performed prior to 
device implantation, revealed an open channel 
between the atria (Fig. 2D). Post-deployment TEE 
and angiography veriﬁ  ed that the device was well-
seated and shunting had been stopped (Figs. 2E, 
2F). Post-procedure saturation testing revealed that 
her resting arterial oxygen saturation had increased 
to 100% in both the supine and standing positions 
with no need for supplemental oxygen. Most impor-
tantly, after physical therapy, the patient returned to 
her prior activity baseline. The patient has remained 
asymptomatic 30 months after device implantation. 
Serial TTEs have revealed no further right-to-left 
shunting and no recrudescence of her pericardial 
effusion with thyroid replacement therapy.
Case #2
A 29-year-old woman with no prior cardiac history 
sought medical attention due to progressive dyspnea 
over the course of six months. Her prior medical 
history was signiﬁ  cant for an episode of idiopathic 
rhomboencephalitis two years prior, complicated 
by a persistent neuropathy. Since that time, she had 
been treated with carbamazepine and had experi-
enced no additional neuropathic problems, but she 
gained in excess of 100 pounds. As a result of this 
weight gain, the patient developed obstructive 
sleep apnea (OSA) approximately fourteen months 
after her rhomboencephalitis. This was treated 
successfully with nighttime CPAP. A pulmonary 
evaluation at that time did not reveal any evidence 
of COPD. Detailed questioning at that time did not 
reveal any risk factors for pulmonary disease. 
Several months after the initiation of CPAP, the 
patient reported dyspnea and a decline in her exer-
tional capacity despite adherence with therapy.
Due to her dyspnea, she initially sought care at 
an urgent care facility close to her home: there, she 
was found to be hypoxemic, with arterial oxygen 
saturations as low as 87%. As a result, she was 
transferred to our hospital. At the time of her initial 
evaluation, she was noted to be resting comfortably 
in a supine position, with oxygen saturation 98% 
on 2 liters/minute nasal cannula supplementation. 
All other vital signs were within normal limits, and 
her pulsus paradoxus was not elevated. The patient 
was morbidly obese, but there were no other note-
worthy ﬁ  ndings on physical exam. Of note, her 
cardiopulmonary exam was within normal limits, 
and there was no other clinical evidence of ﬂ  uid 
overload: her jugular venous pulse was at 6 cm 
H2O, and no lower extremity edema was present. 
There was no evidence of clubbing of the ﬁ  ngers. 
Attempts at ambulation revealed that the patient 
was not able to stand without difﬁ  culty: she would 
become dyspneic, with a drop in her oxygen satu-
rations to 87% on 2 liters/minute nasal cannula 
oxygen. She could only walk a few steps, and noted 
that her symptoms reached maximum intensity 
just after standing. As with the patient described 
in Case #1, only rest in a supine position, not a 
standing position, led to relief.
Chest x-ray and ECG did not reveal any concern-
ing abnormalities. Similarly, laboratory evaluation 
was essentially normal. Chest CT with intravenous 
contrast did not reveal any evidence of signiﬁ  cant 
pulmonary parenchymal or airspace disease. Her 
pulmonary vasculature was also normal, with 
no evidence of thromboembolic disease or AVMs. 
As her platypnea and orthodeoxia raised suspi-
cion for interatrial shunting, an echocardiogram 41
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was performed. This study did not reveal any 
obvious structural abnormalities, but was limited 
by her body habitus. Echocardiography was 
attempted in the standing position, but was not 
successful as the patient was too symptomatic in 
this position to allow for good image acquisition. 
Attempts at estimation of right ventricular systolic 
pressure were not successful. Doppler imaging of 
the interatrial septum did not reveal unequivocal 























Figure 2. Panels A and B) Intra-procedural TEE, prior to device implant. The left atrium is visible at the top of the image (marked LA), with 
the right atrium directly beneath (marked RA). The interatrial septum is marked with a white arrow in both images. Comparison of panels A 
and B reveals the mobility of the interatrial septum. Panel C) Intra-procedural TEE with Doppler, prior to device implant. The left atrium is 
visible at the top of the image (marked LA). The interatrial septum is marked with an arrow. Doppler imaging reveals a ﬂ  ow jet emanating 
from the interatrial septum: this blue-colored jet is moving away from the probe, indicating a left-to-right shunt is present while the patient is 
in the supine position. Panel D) Intra-procedural angiogram (LAO cranial view) prior to device implant. The right atrium is visible on the left 
side of the image, opaciﬁ  ed with contrast (marked RA). The superior vena cava (marked SVC) is also marked with contrast. The right ven-
tricle, marked RV, contains a small amount of contrast. A pigtail catheter is present in the right atrium, with the tip of the catheter in the PFO 
ﬂ  ap. A small wisp of contrast is visible passing through the PFO into the left atrium (marked LA). Panel E) Intra-procedural TEE with Doppler, 
after device implant. As in the other TEE panels, the left atrium (marked LA) is visible at the top of the image, with the right atrium directly 
beneath (marked RA). The echo-dense structure in the area of the interatrial septum is the occlusion device. There is no signiﬁ  cant Doppler 
ﬂ  ow across the device. Panel F) Intra-procedural angiogram (LAO cranial view, identical to the view in 2D) after the placement of the occlu-
sion device. The pigtail catheter present in the right atrium. (RA) was used to opacify the right atrium, superior vena cava (SVC), and right 
ventricle (RV) with contrast. The occlusion device is visible at the boundary between the left and right atria. No passage of contrast into the 
left atrium (LA) is visible.42
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however, did reveal a right-to-left shunt. This shunt 
was not present at all times: a Valsalva maneuver 
was required to elicit shunt of contrast from the 
right to the left atrium (Figs. 3A, 3B).
Since her presenting symptoms were severe, 
and were thought to be caused by right-to-left 
interatrial shunting, she was considered for device 
closure of her PFO/ASD. She was brought to the 
cardiac catheterization laboratory, where a right-
heart catheterization was performed. This revealed 
elevated right heart pressures: RA 15 mmHg, RV 
36/15 mmHg. Pulmonary capillary wedge pressure 
was within normal limits: the elevation in her right 
heart pressures was presumed to be secondary to 
her body habitus-related sleep apnea.
Trans-esophageal echocardiography was 
performed during cardiac catheterization. This 
veriﬁ  ed the presence of a small aperture at the 
inferior aspect of the interatrial septum. As with 
the patient described in Case #1, a septal occlusion 
device (Amplatzer) was used successfully to close 
the aperture. Post-deployment use of bubble 
contrast revealed that the device was well-seated 
and that no residual right to left shunting was 
present (Figs. 3C, 3D). After deployment of the 
aforementioned device, the patient’s oxygen 
saturations in the supine and standing positions 
were re-checked, and were found to be 100% in both 
positions with no supplemental oxygen. The patient 









Figure 3. Panel A) TTE, apical four-chamber view. This image was obtained while the patient was breathing normally. Bubble contrast has 
opaciﬁ  ed the right atrium (arrow). There is no evidence of bubble contrast in the left heart: left atrium and left ventricle are marked LA and 
LV, respectively. Prolonged imaging after contrast injection did not reveal late appearance of contrast in the left heart, indicating that a 
pulmonary shunt is not likely present (data not shown). Panel B) TTE, apical four-chamber view. This image was obtained during the Valsalva 
maneuver. Bubble contrast has opaciﬁ  ed the right heart (arrow). Contrast has opaciﬁ  ed the left atrium (LA) and a signiﬁ  cant amount of 
contrast is visible in the left ventricle (LV): this contrast appeared within three cardiac cycles after contrast reached the right heart. 
Panel C) Intraprocedural TEE without bubble contrast, performed after the occlusion device was percutaneously deployed. The left atrium 
(LA) is visible at the top of the image, with the interatrial septum and the right atrium (RA) beneath. The echo-dense mass in the interatrial 
septum is the device (arrow). Panel D) Intraprocedural TEE with bubble contrast, performed after the occlusion device was percutaneously 
deployed. The view in this image is identical to that in Figure 3C with the exception of contrast. Opaciﬁ  cation of the right atrium (RA) is visible 
in this image, with no evidence of passage of contrast across the device (arrow) into the left atrium (LA).43
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complaint. Soon thereafter, her exertional capacity 
returned to her pre-illness baseline. She has 
remained symptom-free for 30 months after device 
placement.
Discussion
Platypnea-orthodeoxia syndrome is a relatively 
rare manifestation of shunting of blood from the 
right to the left heart, generally through a defect in 
the interatrial septum. PFOs are highly prevalent 
in the general population and are cited as the most 
common underlying cause of this syndrome. Given 
the large difference between the prevalence of PFO 
and platypnea-orthodeoxia syndrome, it appears 
that this interatrial defect is itself not sufﬁ  cient to 
produce clinically evidence issues in most cases. 
It is suspected that platypnea-orthodeoxia syndrome 
is present in patients with an existing PFO in whom 
there is an additional disease process that increases 
right heart pressures. There are several examples 
of such processes, including pulmonary hyperten-
sion and pericardial effusion. The platypnea-
orthodeoxia noted in the patient described in 
Case #1 appears to have been precipitated by her 
hypothyroidism-related pericardial effusion. In the 
patient described in Case #2, the clinical syndrome 
appears to have been set off by pulmonary hyper-
tension related to her OSA. Absent these additional 
processes, the PFO would likely have remained 
clinically quiescent. Transient hemodynamic 
changes, such as those associated with the Valsalva 
maneuver, may be sufﬁ  cient to lead to the passage 
of paradoxical emboli, but do not appear to be 
sufficient to produce platypnea-orthodeoxia 
syndrome. In many cases of platypnea-orthodeoxia 
syndrome, the positional shifts on arterial oxygen 
saturation levels are not as dramatic as those asso-
ciated with the cases discussed here. This empha-
sizes the point that right-to-left shunting ought to 
be actively considered in patients whose blood 
oxygenation falls short of a predicted level (with 
oxygen supplementation) even when a clear posi-
tional component is not present. Correction of the 
non-cardiac insult (e.g. pulmonary hypertension) 
may be sufﬁ  cient to improve, if not correct, the 
relative hypoxia associated with the shunt. In many 
cases, however, correction of the interatrial shunt 
through physical occlusion may not be avoidable. 
In Case #1, drainage of the pericardial effusion led 
to a decrease in right heart pressures and an 
improvement, but no a disappearance in her clinical 
syndrome. In Case #2, the patient was already 
receiving appropriate therapy for OSA when her 
platypnea-orthodeoxia-related symptoms started.
Surgical correction is traditionally the treatment 
of choice for platypnea-orthodeoxia associated 
with interatrial shunting. For patients with suitable 
anatomy, such as PFO or ASD sufﬁ  ciently sepa-
rated from adjoining structures, closure with a 
percutaneously deployed device represents a less 
invasive alternative.
10 Several registries have 
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